Aptamer Selection Using Genetic Algorithms and Parallel Sequencing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The SELEX process for generating aptamers is limited by its reliance on chance and inefficiency in searching the vast aptamer search space, often missing the globally best fitting aptamer and struggling with multiple protein targets or proteins masked in a background, due to its exponential nature and dependence on initial library diversity.

Innovation Solution

The application of a Genetic Algorithm paradigm to direct polymeric sequence evolution, using a fitness function to select and evolve candidate aptamer sequences, allowing for random or directed changes to create a new mixture that converges on optimal aptamers for a target molecule, leveraging massively parallel DNA sequencing for quantification and selection.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If SELEX process is used to generate aptamers, then aptamers can be obtained through in vitro evolution, but the process relies on chance and is inefficient in searching the vast aptamer search space

Engineering Contradiction:
Improvereliability of aptamer selectionVSAvoidefficiency of search process
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent implements feedback by using massively parallel sequencing to quantify aptamer binding affinity and incorporating this information back into the selection process. The fitness function uses sequencing data to identify and select high-affinity aptamers, creating a closed-loop system that continuously improves selection reliability while maintaining high search efficiency through parallel processing.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The patent replaces the traditional mechanical SELEX process with a computational approach using genetic algorithms and massively parallel sequencing. Instead of relying on physical partitioning and manual selection, the system uses digital fitness functions and automated sequencing to evaluate and select aptamers, significantly improving both reliability and productivity.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Adaptability or versatility

If SELEX process is used, then aptamers can be selected through iterative binding and partitioning, but it struggles with multiple protein targets or proteins masked in a background

Engineering Contradiction:
Improveability to handle multiple targetsVSAvoidspecificity of aptamer-target binding
Core Design Contradiction:
Adaptability or versatilityVSMeasurement precision

Solution Approach 1:

The patent creates a universal selection system that can simultaneously identify aptamers for multiple protein targets using a single pooled approach. The fitness function is designed to evaluate binding affinity across all targets, allowing the system to handle multiple targets and masked proteins without requiring separate selection experiments for each target.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The patent introduces massively parallel sequencing as an intermediary tool that bridges the gap between binding assays and aptamer selection. This intermediary provides quantitative fitness data that enables precise discrimination between aptamers binding to different targets, even when targets are present in complex mixtures or at varying concentrations.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Manufacturing precision

If SELEX process is used, then aptamers can be generated through exponential enrichment, but it takes significant time and resources to exhaustively search the search space

Engineering Contradiction:
Improvequality of selected aptamersVSAvoidexperimental time required
Core Design Contradiction:
Manufacturing precisionVSLoss of time

Solution Approach 1:

The patent performs preliminary actions by using computational fitness functions to pre-evaluate and rank potential aptamers before physical selection. The genetic algorithm framework pre-processes the search space through computational modeling, allowing the experimental system to focus only on the most promising candidates, thereby reducing time while maintaining high aptamer quality.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent uses massively parallel sequencing to create digital copies and quantifications of aptamer binding events. Instead of physically processing every possible aptamer through exhaustive SELEX cycles, the system creates computational replicas through sequencing data, enabling rapid evaluation of thousands of candidates simultaneously and dramatically reducing experimental time.

Inventive Principle:
Principle #26Copying

4Adaptability or versatility

If random sequences are used in SELEX, then the search space is maximized, but the finding of selective aptamers relies entirely on chance

Engineering Contradiction:
Improvediversity of candidate sequencesVSAvoidpredictability of aptamer discovery
Core Design Contradiction:
Adaptability or versatilityVSReliability

Solution Approach 1:

The patent applies local quality by allowing different regions of the aptamer sequence to have different degrees of randomness. The fitness function evaluates specific local features (such as binding motifs or structural elements) and applies selective pressure to those regions, while maintaining randomness in other regions. This creates a balanced approach that preserves diversity where needed while ensuring reliability in critical binding regions.

Inventive Principle:
Principle #3Local quality

Data Source

PatentEP2209914B2Method of selecting aptamers
Publication Date: 2017.07.26 CARIS LIFE SCI LUXEMBOURG HLDG

AI summary

The present invention is a method for the identification of one or more aptamers to at least one target molecule, the method comprising: selecting candidate aptamer sequences that bind to a target molecule, assigning to the bound sequences a measure (fitness function) of each sequence's aptameric potential, allowing evolution of some or all of the sequences to create a new mixture of candidate sequences, and repeating the method with the newly created candidate aptamer pool until the aggregate aptameric potential of the candidate pool reaches a plateau, wherein sequences present in the final pool are optimal aptamers to the target molecule.